Press "Enter" to skip to content

Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief, studies find

New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.